Glenmark Pharma Ltd.

BSE: 532296 | NSE: GLENMARK |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE935A01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Glenmark Pharm Glenmark Pharma Ltd. | BSE 1980.10 9.35 (0.47%) | NSE 1978.00 10.30 (0.52%) | Trade | Add

BSE Live

Jan 27, 12:19

1980.10 9.35 (0.47%)

Volume

AVERAGE VOLUME

5-Day

17,434

10-Day

16,560

30-Day

15,511

12,813

Prev. Close

1970.75
Open Price

1905.55

Bid Price (Qty.)
1976.80 (9)
Offer Price (Qty.)
1979.30 (2)

NSE Live

Jan 27, 12:19

1978.00 10.30 (0.52%)

Volume

AVERAGE VOLUME

5-Day

437,425

10-Day

471,905

30-Day

539,130

269,635

Prev. Close

1967.70
Open Price

1968.40

Bid Price (Qty.)
1978.00 (24)
Offer Price (Qty.)
1978.60 (7)

Financials

Print/Copy to Excel : Go

Balance Sheet of Glenmark Pharma (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	28.22	28.22	28.22	28.22	28.22
Total Share Capital	28.22	28.22	28.22	28.22	28.22
Reserves and Surplus	6,042.29	5,576.97	5,135.26	4,464.31	3,601.42
Total Reserves and Surplus	6,042.29	5,576.97	5,135.26	4,464.31	3,601.42
Total Shareholders Funds	6,070.51	5,605.18	5,163.48	4,492.53	3,629.64
Minority Interest	-0.39	-0.38	-0.37	-0.42	-0.30
NON-CURRENT LIABILITIES
Long Term Borrowings	4,042.99	3,573.75	4,141.78	4,536.34	2,487.30
Deferred Tax Liabilities [Net]	16.45	6.86	0.00	0.00	0.00
Other Long Term Liabilities	429.27	89.14	2.60	32.74	76.99
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	4,488.71	3,669.75	4,144.38	4,569.08	2,564.29
CURRENT LIABILITIES
Short Term Borrowings	442.60	303.02	295.04	187.19	787.42
Trade Payables	2,125.84	2,220.75	1,869.78	1,743.22	1,940.79
Other Current Liabilities	1,042.34	1,058.97	719.03	534.98	1,207.77
Short Term Provisions	515.20	438.35	404.04	237.29	63.26
Total Current Liabilities	4,125.98	4,021.09	3,287.89	2,702.68	3,999.25
Total Capital And Liabilities	14,684.81	13,295.65	12,595.38	11,763.87	10,192.87
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,977.71	2,097.81	1,895.81	1,783.70	1,643.73
Intangible Assets	1,997.95	1,517.71	1,081.64	923.50	892.34
Capital Work-In-Progress	1,090.64	1,234.37	993.34	629.55	497.83
Fixed Assets	6,197.54	5,014.46	4,099.32	3,415.31	3,078.86
Non-Current Investments	24.59	29.66	14.66	15.69	17.20
Deferred Tax Assets [Net]	1,455.71	1,389.81	1,320.26	1,311.27	1,064.88
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	150.45	110.16	120.34	99.06	70.15
Total Non-Current Assets	7,881.19	6,598.82	5,606.69	4,889.23	4,288.57
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	2,135.62	2,252.07	2,030.59	2,139.05	1,567.76
Trade Receivables	2,408.96	2,194.59	2,331.81	2,404.32	2,492.65
Cash And Cash Equivalents	1,111.24	937.77	1,234.69	1,057.66	857.12
Short Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
OtherCurrentAssets	1,147.79	1,312.40	1,391.61	1,273.61	986.77
Total Current Assets	6,803.62	6,696.83	6,988.69	6,874.64	5,904.30
Total Assets	14,684.81	13,295.65	12,595.38	11,763.87	10,192.87
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	437.37	239.88	177.62	115.72	143.52
BONUS DETAILS
Bonus Equity Share Capital	15.84	15.84	15.84	15.84	15.84
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.03	0.10	0.00	0.14	0.10
Non-Current Investments Unquoted Book Value	24.56	29.56	14.56	15.56	17.10
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	0.00	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	0.00	0.00	0.00	0.00